Intra-cellular Therapies, Inc. Forecast and Target Price
$128.2
Intra-cellular Therapies, Inc. (ITCI) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Intra-cellular Therapies, Inc. on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Intra-cellular Therapies, Inc. (ITCI) have a share price target of $132. This median of share price forecast represents a 2.96% upside from the latest price of $128.2 as on 06.03.25.
Intra-cellular Therapies, Inc. (ITCI) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Intra-cellular Therapies, Inc. (ITCI) share price will touch around $132 in next 12-months.
Intra-cellular Therapies, Inc. (ITCI) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Intra-cellular Therapies, Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -15.05%
Intra-cellular Therapies, Inc. (ITCI): Difference between Current Price & Median Forecasted Price
Intra-cellular Therapies, Inc. (ITCI) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Intra-cellular Therapies, Inc. (ITCI) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 14 | 13 | 14 |
| Outperform | 6 | 6 | 6 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |